European Cancer Organisation shared a post on LinkedIn:
“Life-saving treatments should reach those in need. Revisions to the EU pharmaceutical legislation aim to help.
The European Parliament Intergroup on Cancer and Rare Diseases will host a public hearing to examine how the new framework can better meet the needs of underserved communities.
The session is co-chaired MEPs Stine Bosse, Tilly Metz, Alessandra Moretti, Tomislav Sokol, and Vlad Voiculescu.
Patient advocates, academic experts, health insurers, and regulatory representatives will bring insights from across the healthcare landscape.
The hearing is open to the public (badge required)
Conference Room N3.1 in the European Parliament in Strasbourg, from 10:30 to 12:00 CEST
More posts featuring European Cancer Organisation on OncoDaily.